Free Trial

Sunshine Biopharma (SBFM) Competitors

Sunshine Biopharma logo
$2.09 -0.11 (-5.00%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$2.06 -0.03 (-1.67%)
As of 10/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SBFM vs. TAOX, AKTX, RNTX, IMA, SONN, CVKD, LNAI, DARE, PASG, and ENLV

Should you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include Synaptogenix (TAOX), Akari Therapeutics (AKTX), Rein Therapeutics (RNTX), ImageneBio (IMA), Sonnet BioTherapeutics (SONN), Cadrenal Therapeutics (CVKD), Lunai Bioworks (LNAI), Dare Bioscience (DARE), Passage Bio (PASG), and Enlivex Therapeutics (ENLV). These companies are all part of the "pharmaceutical products" industry.

Sunshine Biopharma vs. Its Competitors

Sunshine Biopharma (NASDAQ:SBFM) and Synaptogenix (NASDAQ:TAOX) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

Synaptogenix has a net margin of 0.00% compared to Sunshine Biopharma's net margin of -17.35%. Sunshine Biopharma's return on equity of -26.04% beat Synaptogenix's return on equity.

Company Net Margins Return on Equity Return on Assets
Sunshine Biopharma-17.35% -26.04% -20.72%
Synaptogenix N/A -277.76%-150.79%

In the previous week, Sunshine Biopharma had 2 more articles in the media than Synaptogenix. MarketBeat recorded 4 mentions for Sunshine Biopharma and 2 mentions for Synaptogenix. Sunshine Biopharma's average media sentiment score of 0.16 beat Synaptogenix's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sunshine Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Synaptogenix
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sunshine Biopharma has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, Synaptogenix has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500.

Sunshine Biopharma presently has a consensus price target of $7.00, indicating a potential upside of 234.93%. Given Sunshine Biopharma's stronger consensus rating and higher possible upside, analysts clearly believe Sunshine Biopharma is more favorable than Synaptogenix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sunshine Biopharma
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Synaptogenix
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

42.0% of Sunshine Biopharma shares are owned by institutional investors. Comparatively, 10.3% of Synaptogenix shares are owned by institutional investors. 0.1% of Sunshine Biopharma shares are owned by insiders. Comparatively, 2.7% of Synaptogenix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Sunshine Biopharma has higher revenue and earnings than Synaptogenix. Synaptogenix is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$36.34M0.26-$5.13M-$150.88-0.01
Synaptogenix$3.96K6,363.20-$12.77M-$20.16-0.36

Summary

Sunshine Biopharma beats Synaptogenix on 11 of the 16 factors compared between the two stocks.

Get Sunshine Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBFM vs. The Competition

MetricSunshine BiopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$10.02M$3.40B$6.10B$10.49B
Dividend YieldN/A2.28%5.73%4.80%
P/E Ratio-0.0123.1685.3827.13
Price / Sales0.26269.13520.13179.96
Price / CashN/A47.1837.2361.22
Price / Book0.2310.4112.236.52
Net Income-$5.13M-$52.77M$3.33B$276.93M
7 Day Performance34.84%2.31%1.18%1.93%
1 Month Performance41.12%11.13%6.16%2.19%
1 Year Performance-30.56%11.12%60.00%35.00%

Sunshine Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBFM
Sunshine Biopharma
2.5946 of 5 stars
$2.09
-5.0%
$7.00
+234.9%
-30.3%$10.02M$36.34M-0.013News Coverage
Gap Down
TAOX
Synaptogenix
0.0603 of 5 stars
$9.02
-5.5%
N/AN/A$31.48MN/A-0.454News Coverage
Gap Up
AKTX
Akari Therapeutics
2.6381 of 5 stars
$0.96
+2.2%
$3.30
+242.7%
-65.7%$31.38MN/A0.009News Coverage
Short Interest ↑
Gap Up
RNTX
Rein Therapeutics
2.6336 of 5 stars
$1.33
+0.8%
$10.00
+651.9%
N/A$31.00MN/A-0.499
IMA
ImageneBio
2.8471 of 5 stars
$7.60
-1.2%
$35.50
+367.1%
-63.3%$30.48M$9.16M-0.9970Negative News
Short Interest ↑
SONN
Sonnet BioTherapeutics
1.6971 of 5 stars
$4.37
-0.1%
$20.00
+358.2%
-40.6%$29.81M$20K0.0010News Coverage
CVKD
Cadrenal Therapeutics
2.9072 of 5 stars
$13.98
-0.1%
$32.00
+128.9%
-16.4%$28.66MN/A-1.574
LNAI
Lunai Bioworks
N/A$1.23
+6.0%
N/AN/A$28.51MN/A-0.1620News Coverage
DARE
Dare Bioscience
2.5248 of 5 stars
$2.08
-1.9%
$10.00
+380.8%
-43.6%$28.05M$10K-0.9730Positive News
PASG
Passage Bio
3.0967 of 5 stars
$8.61
-1.0%
$75.67
+779.3%
-32.3%$27.36MN/A-0.47130Gap Down
ENLV
Enlivex Therapeutics
2.6888 of 5 stars
$1.11
+0.9%
$10.00
+800.9%
-35.0%$26.96MN/A-1.9170News Coverage

Related Companies and Tools


This page (NASDAQ:SBFM) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners